Detection of galectin-3 in patients with inflammatory bowel diseases: new serum marker of active forms of IBD?
✍ Scribed by Lenka Frol’ová; Karel Smetana; Dana Borovská; Andrea Kitanovičová; Klára Klimešová; Ivana Janatková; Karin Malíčková; Milan Lukáš; Pavel Drastich; Zdeněk Beneš; Ludmila Tučková; Joachim C. Manning; Sabine André; Hans-Joachim Gabius; Helena Tlaskalová-Hogenová
- Publisher
- SP Birkhäuser Verlag Basel
- Year
- 2009
- Tongue
- English
- Weight
- 645 KB
- Volume
- 58
- Category
- Article
- ISSN
- 1420-908X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: The pathogenesis of inflammatory bowel disease (ibd) involves the interaction between genetic susceptibility, mucosal immunity, and intestinal bacteria. bacterial translocation is a common event in these patients and plays an important role in the perpetuation of chronic intestinal i
The purpose of this study was to evaluate the use of the acute-phase serum protein a,-antitrypsin (a,- AT) compared with the erythrocyte sedimentation rate (ESR), platelet count, and hemoglobin level in screening for inflammation in newly diagnosed and known patients with inflammatory bowel disease